CD25-APC (Clone REA570) - Clone REA570 recognizes the human CD25 - Miltenyi Biotec B.V. & Co. KG

Duns Number:342920388

Device Description: Clone REA570 recognizes the human CD25 glycoprotein, also known as the low-affinity interl Clone REA570 recognizes the human CD25 glycoprotein, also known as the low-affinity interleukin-2 receptor alpha chain (IL-2Ralpha). It associates with IL-2 receptor beta (CD122) and gamma chains (CD132) to form a high affinity IL-2R complex. CD25 is expressed on activated T and B cells, on macrophages, and on a subset of non-activated CD4+ regulatory T cells. Clone REA570 recognizes epitope region A. Additional information: Clone REA570 displays negligible binding to Fc receptors

Want to know more about this Product? Request more information now!


More Product Details

Catalog Number

-

Brand Name

CD25-APC (Clone REA570)

Version/Model Number

170-081-060

Device Commercial Distribution Status

In Commercial Distribution

Commercial Distribution End Date

-

Issuing Agency

In GS1

Product Characteristics

MRI safety Status

Labeling does not contain MRI Safety Information

Device required to be labeled as containing natural rubber latex or dry natural rubber (21 CFR 801.437)

-

Device labeled as "Not made with natural rubber latex"

-

For Single-Use

-

Prescription Use (Rx)

-

Over the Counter (OTC)

-

Kit

-

Combination Product

-

Human Cell, Tissue or Cellular or Tissue-Based Product (HCT/P)

-

FDA Premarket Submission

-

Product Code Details

Product Code

MVU

Product Code Name

Reagents, Specific, Analyte

Device Record Status

Public Device Record Key

74e3c475-9ab6-4b38-b0b6-d324fdcd72f1

Public Version Date

April 05, 2021

Public Version Number

1

DI Record Publish Date

March 26, 2021

Additional Identifiers

Package DI Number

None

Quantity per Package

-

Contains DI Package

-

Package Discontinue Date

-

Package Status

-

Package Type

-

"MILTENYI BIOTEC B.V. & CO. KG" Characteristics
Device Class Device Class Description No of Devices
1 A medical device with low to moderate risk that requires general controls 88